0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover1464.20%IV231.13%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.6476Delta0.1247Gamma2.16Leverage Ratio-0.0889Theta0.0001Rho1.40Eff Leverage0.0008Vega
Wallbox Stock Discussion
NEWS
Wallbox Announces Six Month Milestones in The Acquisition of ABL, A German Leader in EV Charging
The company's shares have gained a cumulative 102% so far this year. Nonetheless, its shares are still down about 39% from the all-time high of nearly $410 per share set in November 2021 .
Traders shorting Tesla shares have accumulat...
$ChargePoint(CHPT.US)$, the largest U.S. producer of EV charging stations, is rolling out an advertising display business.
This EV charging-station operator will create a nationwide advertising network in p...
• $ironSource(IS.US)$ +65% (Unity (U) confirms merger agreement with ironSource)
• $Stitch Fix(SFIX.US)$ +8% (director purchases 1 mln shares)
• $Wallbox(WBX.US)$ +7.4% (Wallbox and Svea Solar announce a new partnership to integrate solar and EV charging)
• $Myriad Genetics(MYGN.US)$ +5.2% (new study by VA shows Major Depressive Disorder remission rates were significantly improved with GeneSight)
• $Golub Capital BDC(GBDC.US)$...
• $Air Products & Chemicals(APD.US)$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $290 (from $288)
• $CME Group(CME.US)$ : Oppenheimer Upgrades to Outperform from Perform - PT $223
• $Equitable(EQH.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $36
• $Diamondback Energy(FANG.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $160 (from $162)
• $Kilroy Realty Corp(KRC.US)$ : Goldman Sachs Upgrades to Buy from Neu...
• $SailPoint Technologies(SAIL.US)$ +30% (confirms agreement to be acquired by Thoma Bravo for $6.9 bln; stockholders to receive $65.25 per share in cash)
• $Veru Inc(VERU.US)$ +28.9% (Novel COVID-19 Drug Candidate Reduces Deaths by 55% in Hospitalized Patients in Interim Analysis of Phase 3 Study; Independent Data Monitoring Committee Halts Study Early for Overwhelming Efficacy)
• $Affimed NV(AFMD.US)$ +12.9% (Presents Upda...
No comment yet